Abstract
Damage to the liver is a common clinical consequence of chronic diabetes mellitus type 2 (DM2). This study evaluates whether ultrasound shear wave elastography and hemodynamics of the portal vein and the hepatic artery can complement traditional clinical work-up data for the monitoring of liver health among DM2 patients. Methods: Sixty-four (64) participants (31 controls and 33 patients with confirmed type 2 diabetes mellitus) between 21 to 74 years of age were recruited. Liver size, stiffness and hemodynamics of the portal vein and the hepatic artery were evaluated. Glycated hemoglobin (HbA1c), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) were monitored. Student’s t-test was employed with significance attained at p <0.05. Results: Asymptomatic significant differences were detected among DMT2 patients: (1) Largest Liver size (p=0.04); (2) Higher liver stiffness (p=0.04); (3) Higher alkaline phosphate levels (p=0.03); (4) Higher HbA1c levels (<0.001) and (7) presence of moderate to severe liver fibrosis. DM2 F1 stage has higher liver stiffness (0.006) and HbA1c levels (<0.001).
Highlights
Damage to the liver is a common clinical (NAFLD), with significant anatomical and physiological consequence of chronic diabetes mellitus type 2 (DM2)
We aim to determine whether the use of shear wave hepatic elastography can complement traditional clinical work-up data for the monitoring of liver health among DM2 patients
Normality was assessed by the Shapiro-Wilk test and b) Laboratory test results homogeneity of variance was evaluated according to Laboratory test results were obtained from normality results
Summary
Damage to the liver is a common clinical (NAFLD), with significant anatomical and physiological consequence of chronic diabetes mellitus type 2 (DM2). NAFLD is a worldwide study evaluates whether ultrasound shear wave elastography epidemic of great financial impact with an estimated and hemodynamics of the portal vein and the hepatic artery can complement traditional clinical work-up data for the monitoring of liver health among DM2 patients. Prevalence as high as 30% of the worldwide population, most likely due to the fact that obesity and diabetes are risk factors of this fatal condition when left untreated.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
